tiprankstipranks
Bio-Path Holdings Expands DNAbilize® Technology Applications
PremiumCompany AnnouncementsBio-Path Holdings Expands DNAbilize® Technology Applications
1M ago
Bio-Path reports Q3 EPS (70c) vs. ($6.36) last year
Premium
The Fly
Bio-Path reports Q3 EPS (70c) vs. ($6.36) last year
1M ago
Is BPTH a Buy, Before Earnings?
Premium
Pre-Earnings
Is BPTH a Buy, Before Earnings?
1M ago
Bio-Path prices $4.0M at-the-market offering for $0.87 per share
PremiumThe FlyBio-Path prices $4.0M at-the-market offering for $0.87 per share
2M ago
Morning Movers: Roblox drops following short report
Premium
The Fly
Morning Movers: Roblox drops following short report
2M ago
Bio-Path initiates development of therapeutic program for obestiy treatment
Premium
The Fly
Bio-Path initiates development of therapeutic program for obestiy treatment
2M ago
Bio-Path reports Q2 EPS ($1.16) vs ($10.64) last year
PremiumThe FlyBio-Path reports Q2 EPS ($1.16) vs ($10.64) last year
4M ago
BPTH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
BPTH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Bio-Path provides clinical update, expansion plans
Premium
The Fly
Bio-Path provides clinical update, expansion plans
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100